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In Brief
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function. L1 retrotransposons mobilize
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genes, suggesting functional
significance.
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SUMMARY

Somatic LINE-1 (L1) retrotransposition during neurogenesis is a potential source of genotypic variation
among neurons. As a neurogenic niche, the hippocampus supports pronounced L1 activity. However,
the basal parameters and biological impact of L1driven mosaicism remain unclear. Here, we performed
single-cell retrotransposon capture sequencing (RCseq) on individual human hippocampal neurons and
glia, as well as cortical neurons. An estimated 13.7 somatic L1 insertions occurred per hippocampal neuron
and carried the sequence hallmarks of target-primed
reverse transcription. Notably, hippocampal neuron
L1 insertions were specifically enriched in transcribed
neuronal stem cell enhancers and hippocampus
genes, increasing their probability of functional relevance. In addition, bias against intronic L1 insertions
sense oriented relative to their host gene was
observed, perhaps indicating moderate selection
against this configuration in vivo. These experiments
demonstrate pervasive L1 mosaicism at genomic
loci expressed in hippocampal neurons.
INTRODUCTION
The extent to which the genome of one cell differs from that
of any other cell from the same body is unclear. DNA replication
errors, mitotic recombination, aneuploidy, and transposable
element activity can cause somatic mosaicism during ontogenesis and senescence. In humans, the consequences of somatic
mosaicism are most apparent in disease, including cancer and
developmental syndromes (Youssoufian and Pyeritz, 2002).
The impact of mosaicism among normal cells is relatively undefined beyond the notable exception of V(D)J recombination
and somatic hypermutation intrinsic to lymphocyte antigen
recognition (Hozumi and Tonegawa, 1976). Reports of retrotransposition (Baillie et al., 2011; Coufal et al., 2009; Evrony
et al., 2012; Li et al., 2013; Muotri et al., 2005; Perrat et al.,
2013) and other genomic abnormalities (Cai et al., 2014; Gole
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et al., 2013; McConnell et al., 2013) in animal neurons may therefore be important given that, as for immune cells, mosaicism is a
plausible route to neuron functional diversification.
Of approximately 500,000 LINE-1 (L1) copies present in the
human genome, only 100 members of the L1-Ta and pre-Ta
subfamilies remain transposition-competent (Beck et al., 2010;
Brouha et al., 2003). L1 mobilization primarily occurs via target
primed reverse transcription (TPRT), a process catalyzed in cis
by two proteins, ORF1p and ORF2p, translated from the bicistronic 6 kb L1 mRNA. L1 ORF2p encodes endonuclease (EN)
and reverse transcriptase (RT) activities essential to L1 retrotransposition and also responsible for trans mobilization of Alu
and SVA retrotransposons (Dewannieux et al., 2003; Hancks
et al., 2011; Raiz et al., 2012). A typical TPRT-mediated L1 insertion involves a degenerate L1 EN recognition motif (50 -TT/AAAA),
an L1 poly-A tail and, crucially, produces target site duplications
(TSDs) (Jurka, 1997; Luan et al., 1993). Various host defense
mechanisms suppress L1 activity (Beck et al., 2011), including
via methylation of the CpG-rich L1 promoter. Neural progenitors
and other multipotent cells can nonetheless permit L1 promoter
activation (Coufal et al., 2009; Garcia-Perez et al., 2007; Wissing
et al., 2012), a pattern accentuated in the hippocampus, likely
due to its incorporation of the neurogenic subgranular zone (Baillie et al., 2011; Coufal et al., 2009). This coincidence of neurogenesis, L1 activity, and mosaicism has elicited speculation that L1
mobilization could impact cognitive function rooted in the hippocampus (Richardson et al., 2014).
Despite extensive evidence of somatic retrotransposition
in the brain, many fundamental aspects of the phenomenon
remain unclear. The rate of L1 mobilization in the neuronal lineage is, for instance, a major unresolved issue. Estimates range
from <0.1 to 80 somatic L1 insertions per neuron (Coufal et al.,
2009; Evrony et al., 2012). Experiments using engineered L1 reporter systems have shown that L1 mobilization is likely to occur
via TPRT in neuronal precursor cells and may be altered by
neurological disease (Coufal et al., 2011; Coufal et al., 2009;
Muotri et al., 2005; Muotri et al., 2010). However, it is unknown
whether endogenous L1 retrotransposition in hippocampal neurons adheres to these predictions. Most importantly, it is unclear
whether somatic L1 insertions influence neuronal phenotype or
endow carrier neuronal progenitor cells with a selective advantage or disadvantage in vivo. To address these questions, we

Figure 1. Single-Cell RC-Seq Workflow
(A) NeuN+ hippocampal nuclei were first purified by FACS (see also Figure S1).
(B) Nuclei were then picked using a self-contained microscope and micromanipulator.
(C) DNA was extracted from nuclei and subjected to linear WGA, followed by exponential PCR in two separate reactions for each nucleus, using different
enzymes.
(D) Exponential WGA products for each nucleus were combined, used to prepare Illumina libraries, and analyzed via WGS to assess genome coverage and
possible amplification biases.
(E) Libraries prepared in (D) were enriched via hybridization to L1-Ta LNA probes.
(F) Enriched libraries were sequenced with 2 3 150-mer Illumina reads and analyzed to identify novel L1 integration sites (see also Figure S2).

applied single-cell retrotransposon capture sequencing (RCseq) to hippocampal neurons and glia, as well as cortical neurons, and found that L1 retrotransposition is a major endogenous
driver of somatic mosaicism in the brain.
RESULTS
Pervasive L1 Mobilization in Hippocampal Neurons
Several biological and technical factors hinder accurate calculation of somatic L1 mobilization frequency using bulk DNA extracted from tissue, as well as subsequent PCR validation and
structural characterization of individual somatic L1 insertions
(Richardson et al., 2014). We therefore developed a single-cell
RC-seq protocol to detect somatic L1 insertions in individual
neurons. Briefly, NeuN+ hippocampal nuclei were purified by
fluorescence activated cell sorting (FACS) (Figures 1A and S1),
with single nuclei isolated using a self-contained microscope
and micromanipulator (Figure 1B). Whole-genome amplification
(WGA) was achieved through an extensively optimized version of
the quasi-linear Multiple Annealing and Looping Based Amplification Cycles (MALBAC) protocol (Zong et al., 2012) and
was followed by Illumina library preparation (Figures 1C and

1D). Libraries were then subjected to low-coverage (0.353)
whole-genome sequencing (WGS) as a quality control step to
assess amplification bias and, in parallel, hybridized and processed by RC-seq (Figures 1E and 1F).
RC-seq utilizes sequence capture to enrich DNA for the junctions between retrotransposon termini and adjacent genomic
regions, followed by paired-end sequencing, alignment, and
clustering, to reveal L1 insertions absent from the reference
genome. Here, we replaced previous RC-seq sequence capture
pools (Baillie et al., 2011; Shukla et al., 2013) with two locked nucleic acid (LNA) probes respectively targeting the extreme 50 and
30 ends of L1-Ta. These probes capture typical L1 insertions at a
30 L1-genome junction, and full-length or heavily 50 truncated L1
insertions at a 50 L1-genome junction (Figure S2), and delivered a
15-fold improvement in L1 enrichment compared with previous
RC-seq applied to brain (Baillie et al., 2011). Assembly of each
overlapping read pair into a ‘‘contig’’ enabled computational
identification of molecular chimeras and removal of PCR duplicates, and provided single-nucleotide resolution of L1 integration sites by fully spanning L1-genome junctions (Figure S2).
Prior to single-cell RC-seq, we performed deep coverage
(803) RC-seq on bulk DNA extracted from the post-mortem
Cell 161, 228–239, April 9, 2015 ª2015 The Authors 229

Figure 2. Single-Cell WGS and RC-Seq Analyses of 92 Hippocampal Neurons
(A) Chromosome copy number in each amplified
genome, assessed by WGS. Box-and-whisker
plots indicate median chromosomal copy number
and quartiles across all neurons. Empty circles
represent chromosomes with copy number >1.5
IQR from the median. Sex chromosomes for
CTRL-36 (female, \) and CTRL-42, CTRL-45, and
CTRL-55 (male, _) are presented separately. Six
autosomes, marked in red, had copy number % 1.
Two sex chromosomes with log2 copy number <
2 are colored purple.
(B) WGS indicated 16.2 Mb and 9.4 Mb regions of
localized AD (indicated by red bars) on chromosome 6 of neuron CTRL-45-HN-#2. Each blue
diamond corresponds to a 600 kb ‘‘bin’’. One bin
with log2 copy number < 5 is colored purple.
(C) Percentages of LD (dark gray) and AD (light
gray) bins in each neuron, assessed by WGS.
(D) Percentage of reference genome L1-Ta copies
detected by single-cell RC-seq in each neuron.
(E) Percentage of polymorphic L1-Ta insertions
found in the corresponding bulk RC-seq libraries
for each individual and also detected by single-cell
RC-seq.
(F) Somatic L1 insertion counts observed in each
neuron by single-cell RC-seq.
Note: in (C-F) yellow, brown, blue, and green
histogram columns correspond to individuals
CTRL-36, CTRL-42, CTRL-45, and CTRL-55,
respectively. See also Figures S3 and S4 and Tables S1 and S2.

hippocampus and matched liver samples of four individuals
(identifiers CTRL-36, CTRL-42, CTRL-45, and CTRL-55) without
evidence of neurological disease (Table S1). Bulk RC-seq on
average detected 97.5% of 960 annotated reference genome
L1-Ta copies (Evrony et al., 2012), indicating high assay sensitivity. As expected, we detected 210 polymorphic L1-Ta insertions absent from the reference genome, per individual (Tables
S1 and S2). This defined the polymorphic (germline) L1-Ta
insertion cohort for each individual and provided a positive control for subsequent single-cell RC-seq analyses.
Next, 92 individual neuronal nuclei were isolated from the
aforementioned hippocampi, subjected to WGA and analyzed
by WGS. Globally, WGS revealed that 4,226/4,232 (99.9%) chromosomes amplified (Figure 2A) with recurring WGA bias largely
230 Cell 161, 228–239, April 9, 2015 ª2015 The Authors

limited to telomeres (Figures S3, S4A
and S4B). Higher-resolution copy-number variation (CNV) analysis based on
the division of the genome into adjustable-width ‘‘bins’’ with an average size
of 600 kb revealed five non-telomeric
deletions larger than 5 Mb. The largest
and third largest of these occurred on
chromosome 6 of CTRL-45 hippocampal
neuron 2 (CTRL-45-HN-#2) and were
16.2 Mb and 9.4 Mb in length (Figure 2B).
An alternative CNV analysis using 60 kb
bins indicated the presence of numerous subregions in the 16.2
Mb example where chromosomal copy number was R2 (Figure S4C), depicting a region of highly variable WGA performance
and, arguably, contraindicative of a genuine deletion in vivo.
Genome-wide, allelic dropout (AD) and locus dropout (LD)
respectively affected 8.0% and 0.7% of bins at 600 kb resolution
(Figure 2C, Table S1), indicating efficient amplification across
>90% of the genome. Importantly, we optimized WGA parameters to not deplete L1-Ta copies from amplified DNA, with the
mean ratio of WGS reads aligned to reference L1-Ta 50 or 30
L1-genome junctions at 0.81 and 1.28 of expected values,
respectively (Figures S4D and S4E; Table S1). These results
show robust WGA for individual neurons, without significant
loss of reference genome L1-Ta copies.

Single-cell RC-seq applied to each of the 92 libraries analyzed
by WGS detected 61.3% of reference genome L1-Ta copies
(Figure 2D, Table S1) and 49.0% of polymorphic L1-Ta insertions
in each neuron (Figure 2E), as defined by the earlier bulk RC-seq
experiments. The latter figure provided a provisional estimate of
assay sensitivity for somatic L1 insertions. A total of 2,782 putative somatic L1-Ta and pre-Ta insertions (Figure 2F, Table S2)
were identified in at least one hippocampal neuron, were not
detected in any bulk liver RC-seq library or more than one hippocampus by single-cell or bulk RC-seq, and were absent from existing L1 polymorphism databases (Ewing and Kazazian, 2010,
2011; Iskow et al., 2010; Shukla et al., 2013; Wang et al.,
2006). Of these insertions, 1,024 (36.8%) and 34 (1.2%) were
found in introns and exons, respectively. Twelve (0.4%) somatic
L1 insertions were detected at both their 50 and 30 L1-genome
junctions, 760 (27.3%) at only a 50 junction, and 2,010 (72.3%)
at only a 30 junction. Notably, nine somatic L1 insertions detected
by single-cell RC-seq were also detected and annotated as somatic in the corresponding hippocampus bulk RC-seq library,
and 13 were detected by single-cell RC-seq in more than one
neuron from the same hippocampus. Of somatic L1 insertions,
98.2% belonged to the L1-Ta subfamily, and 1.8% were annotated as pre-Ta. Although at 50 L1-genome junctions RC-seq
captures only full-length and very heavily truncated L1s (Figure S2), we found 123 full-length L1 insertions, representing
4.4% of all events and including two instances of 50 transduction.
Of those insertions detected at their 30 L1-genome junction,
151 (7.5%) carried a putative transduced 30 flanking sequence
(Moran et al., 1999). This L1 30 transduction rate was lower
than reported for germline L1 retrotransposition (Goodier et al.,
2000), likely due to assay design not encompassing 30 transductions longer than 100 bp, as reported elsewhere (Goodier et al.,
2000; Macfarlane et al., 2013).
PCR Validation and Structural Characterization of
Somatic L1 Insertions
To determine the true positive rate of single-cell RC-seq, we
randomly selected 20 somatic L1 insertions detected at only a
30 L1-genome junction and PCR amplified the opposing 50
L1-genome junction. This enabled detection of TPRT sequence
hallmarks that distinguish WGA artifacts from most genuine L1
integration sites; specifically a TSD, an L1 EN target motif and
an L1 poly-A tail (Jurka, 1997; Luan et al., 1993). Through PCR
and sequencing, 50 L1-genome junctions were identified for
nine insertions and, when combined with the corresponding 30
L1-genome junctions described by RC-seq, indicated TSDs
and polyA-tails in all cases, and plausible L1 EN motifs for 7/9
(77.8%) examples (Tables S2 and Data S1). PCR validated insertions included full-length (Figure 3A) and variably 50 truncated
(Figures 3B–F) L1s. Intronic L1 insertions were found sense oriented to two genes expressed in brain, ZFAND3 (Figure 3B)
and USP33 (Table S2). One L1 insertion incorporated a 30 transduction and was detected by PCR in two neurons of CTRL-42
(Figure 3D). Further, PCR applied to the full panels of analyzed
neurons from each individual revealed that two other L1 insertions were present in 10/21 and 2/21 neurons, respectively (Figures 3E and 3F). Three of the validated L1 insertions generated
TSDs >40 bp in length.

These experiments showed that nearly half of somatic L1 insertions detected by single-cell RC-seq at a 30 L1-genome
junction could be confirmed as genuine TPRT-mediated retrotransposition events. By contrast, PCR validation for 10
randomly selected exonic L1 insertions detected at a 50 L1genome junction by single-cell RC-seq failed to find the
opposing 30 L1-genome junction in all cases (Table S2). This
was consistent with the L1 polyA-tail obstructing PCR amplification of somatic L1 insertion 30 ends (Baillie et al., 2011) and
arguably did not resolve whether L1 insertions detected only
at a 50 L1-genome junction were false positives. Finally, we
selected 4 L1 insertions found at both their 50 and 30 L1-genome
junctions by single-cell RC-seq; all four were confirmed by PCR
and presented TPRT hallmarks, including one with a 92 bp TSD
(Table S2).
Nearly 75% of somatic L1 insertions found by single-cell RCseq were detected only at a 30 L1-genome junction (Figure S2).
Given this preponderance, we sought to ascertain why the
matching 50 L1-genome junction could not be identified by
PCR for 11/20 selected examples of this type. PCR amplification
failure was potentially due to RC-seq false positives, structurally
exotic L1 insertions (Gilbert et al., 2005) or, alternatively, WGA
inconsistently amplifying the 50 L1-genome junctions of insertions detected at a 30 L1-genome junction by single-cell RCseq. To model the latter possibility, we randomly selected
12 polymorphic L1 insertions detected by bulk RC-seq and
confirmed as heterozygous by genotype PCR. We performed
PCR using bulk DNA to confirm each insertion was detectable
at its 50 L1-genome junction and then selected 100 random examples in individual neurons where these polymorphic L1s
were detected at only a 30 L1-genome junction by single-cell
RC-seq (Table S2). We attempted PCR amplification of the corresponding 50 L1-genome junction for each neuron, hence recapitulating the validation process for somatic L1 insertions, and
confirmed 50/100 examples. This assay indicated the maximum
PCR validation rate (50.0%) for somatic L1 insertions detected at
only a 30 L1-genome junction by single-cell RC-seq and, given
the validation rate reported above (9/20, 45%), implied a true
positive rate potentially as high as 9/10 (90.0%).
L1 Mobilization Frequency in Diverse Neural Cell
Populations
Single-cell RC-seq identified mean somatic L1 insertion counts
of 48.4, 27.5, 30.5, and 14.8 per hippocampal neuron in CTRL36, CTRL-42, CTRL-45, and CTRL-55, respectively, yielding an
overall mean count of 30.4 (Figure 2F). To estimate the overall
true positive mean, we incorporated the PCR validation rate
(45.0%) calculated above, leading to a conservative rate calculation of 13.7 somatic L1 insertions per hippocampal neuron. If,
more conservatively, only L1 insertions detected at a 30 L1genome junction were considered, the true positive mean was
9.9. Conversely, if all L1 insertions were considered, we generously incorporated the maximum PCR validation rate calculated
above (90%) and we corrected for assay sensitivity in terms of
polymorphic L1 insertions detected (49.0%), the estimated true
positive mean was greatly increased to 55.8. Thus, given a true
positive mean of 13.7 somatic L1 insertions per neuron, and
the detection of at least one event in every neuron (Figure 2F),
Cell 161, 228–239, April 9, 2015 ª2015 The Authors 231

Figure 3. PCR Validation of Somatic L1 Insertions
(A–F) Validated examples from hippocampal
neuron single-cell RC-seq data included: (A) a fulllength L1 insertion in neuron CTRL-42-HN-#13; (B)
a truncated L1 insertion in neuron CTRL-42-HN#11; (C) a heavily truncated L1 insertion in neuron
CTRL-55-HN-#15; and (D) a very heavily truncated
L1 insertion yielding a 30 transduction in neuron
CTRL-42-HN-#4, also validated in neuron CTRL42-HN-#3, and traced to a donor L1-Ta on chromosome 3; (E) a very heavily truncated L1 insertion
detected in CTRL-42-HN-#13 and validated in
10/21 CTRL-42 hippocampal neurons tested.
Asterisks denote neurons where validation succeeded; (F) a very heavily truncated L1 insertion
detected in CTRL-42-HN-#4 and also validated in
CTRL-42-HN-#22. Note: in (A–F) the 30 L1-genome
junction was detected by single-cell RC-seq, while
the 50 L1-genome junction was identified by
insertion-site PCR (using primers indicated by a
and b) and sequencing. Green triangles indicate
TSDs. Numbers below the 50 L1-genome junction
indicate the equivalent L1-Ta consensus position.
See also Table S2 and Data S1.

we concluded that L1 mosaicism was ubiquitous among the hippocampal neurons studied.
Prior in vitro experiments based on an engineered L1 reporter
indicated that glia may support far less L1 mobilization than neurons (Coufal et al., 2009). To evaluate glial lineage endogenous
L1 retrotransposition in vivo, we performed single-cell RC-seq
upon 22 glial nuclei (NeuN/Ki67) isolated from CTRL-42,
CTRL-45, and CTRL-55 hippocampi, and detected 316 putative
somatic L1 insertions (Figures 4A and S5). This produced a mean
true positive estimate of 6.5 insertions per glial cell, based on the
PCR validation rate determined for hippocampal neurons
(45.0%). This rate was 52.6% lower than the estimated 13.7 insertions for hippocampal neurons, a significant difference (p <
0.005, two-tailed t test, df = 112). Interestingly, four insertions
were found in both glial and neuronal cells by single-cell RC232 Cell 161, 228–239, April 9, 2015 ª2015 The Authors

seq, with one of these instances detected
at both its 50 and 30 L1-genome junctions,
revealing a 12 bp TSD (Table S2). We
concluded that L1 insertions can arise in
proliferating neural stem cells prior to glial
or neuronal commitment, while glia otherwise support less L1 mobilization than
neurons.
A recent single-cell genomic analysis of
300 cortex and caudate nucleus pyramidal neurons elucidated <0.1 somatic L1
insertions per cell, and concluded that
L1 was not a major driver of neuronal diversity (Evrony et al., 2012). However,
the biological or technical reasons for
such disparate results compared with
prior data from the hippocampus were
unclear. We therefore performed singlecell RC-seq upon 35 NeuN+ nuclei isolated from CTRL-42,
CTRL-45 and CTRL-55 cortex tissue, including seven pyramidal
neurons, and identified 1,262 putative somatic L1 insertions (Figures 4B and S5). This provided a true positive mean estimate of
16.3 insertions per cortical neuron, a figure higher than hippocampal neurons, but not significantly different. An estimated
10.7 insertions occurred per cortex pyramidal neuron, a rate
substantially lower than the remaining cortical neurons but a difference that fell short of statistical significance (p < 0.16, twotailed t test, df = 33). These data elucidate L1 mosaicism in
cortical neurons and exclude a biological explanation for inconsistency with the previous study.
PCR validation including TSD discovery underpins accurate
calculation of L1 mobilization frequency and reflects experimental veracity independent of methodology (Richardson et al.,

Figure 4. L1 Mobilization in Diverse Neural Cell Types
(A) Somatic L1 insertion counts observed by single-cell RC-seq applied to hippocampal glia.
(B) As for (A) except for cortical neurons. Seven pyramidal neurons are indicated by an asterisk.
(C) As for (A) except for AGS-1 hippocampal neurons.
(D) L1 qPCR indicated lower L1 copy number in AGS-1 hippocampus versus controls (p < 0.002, two-tailed t test, df = 23). Data represent the mean of 5 technical
replicates ± SD.
(E) Mean somatic L1 insertion counts detected by single-cell RC-seq in each hippocampus strongly correlated (R2 = 0.93) with L1 copy number quantified by
qPCR (D).
See also Figure S5 and Table S2.

2014). It is therefore notable that, at this stringency, Evrony et al.
reported a PCR validation rate of 1/96 and a consequential
paucity of L1 activity. Two key technical considerations may
explain our discrepant findings. First, RC-seq reads fully span
L1-genome junctions (Figure S2), enabling bioinformatic identification of molecular chimeras before PCR validation. The earlier
work by contrast followed a design (Ewing and Kazazian, 2010)
that typically did not resolve L1-genome junctions, prohibiting
computational removal of chimeric reads. Instead, the authors
maintained that artifacts, including those generated by WGA
and Illumina library preparation, should present lower read depth
than genuine L1 insertions, and essentially adhered to the same
principle in a very recent study applying WGS to a smaller number
of neurons (Evrony et al., 2015). This assumption is crucial as, at
least in single-cell RC-seq libraries, putative chimeras are disproportionately likely to amplify efficiently and accrue high read
depth (Figures 5A and 5B). Second, Evrony et al. selected candidates for PCR validation effectively as a function of high read
count and not at random (Figure 5C). This approach would
strongly enrich for artifacts if applied to single-cell RC-seq data
(Figure 5B). It follows that, without the capacity to filter artifacts
a priori, the previous study resolved numerous molecular
chimeras after PCR and capillary sequencing of putative L1

insertions, substantially reducing the reported validation rate.
By contrast, we selected PCR validation candidates at random
(Figure 5D). These factors plausibly explain why our validation
rate of 9/20 (45.0%) was significantly higher than the rate of
1/96 (1.0%) reported by the earlier work (p < 1 3 1010, chisquare test, df = 1), as well as the disparate estimates of somatic
L1 retrotransposition made by each study.
Recent qPCR based estimates of L1 CNV in human tissue, as
well as in vitro L1 reporter assays, indicate L1 mobilization may
be pronounced in a range of neurodevelopmental and psychiatric diseases (Richardson et al., 2014) including Aicardi-Goutières
syndrome (AGS). AGS is a rare, severe neurodevelopmental
condition, characterized by mutations in several genes thought
to inhibit reverse transcription, including SAMHD1 (Zhao et al.,
2013). To address whether SAMHD1 deficiency in AGS patients
increases neuronal L1 mobilization, we first applied bulk RC-seq
to the post-mortem hippocampus and fibroblasts of an AGS patient (identifier AGS-1) carrying two loss-of-function SAMHD1
mutations. We then performed single-cell RC-seq upon 21
neuronal nuclei from AGS-1 hippocampus and identified 373 putative somatic L1 insertions (Figures 4C and S5), leading to a true
positive mean estimate of 8.0 insertions per AGS-1 neuron. This
figure was significantly (p < 0.03, two-tailed t test, df = 112) lower
Cell 161, 228–239, April 9, 2015 ª2015 The Authors 233

Figure 6. Hallmarks of TPRT Revealed by Bulk RC-Seq
Figure 5. Single-Cell RC-Seq Efficiently Excludes Molecular
Artifacts
(A) Distribution of read ‘‘peaks’’ indicating possible somatic L1 insertions detected by single-neuron L1 insertion profiling (L1-IP) (Evrony et al., 2012).
(B) As for (A), except for all single-cell RC-seq data presented here. Peaks were
annotated as chimeric or as likely genuine L1 insertions by sequence analysis
of RC-seq reads.
(C) Distribution of read peak height for L1 insertions selected for validation by
Evrony et al. The L1 insertion successfully validated by TSD discovery is
colored black. The remaining insertions not validated to this standard are
colored red.
(D) As for (C), except for L1 insertions detected by single-cell RC-seq and
selected at random for validation.

than the 13.7 somatic L1 insertions found for control hippocampal neurons. A more significant difference was observed when
AGS-1 neurons were compared only with the age (18 years)
and gender (female) matched hippocampal neurons of CTRL36 (p < 0.0001, two-tailed t test, df = 44). As corollary, L1
qPCR also indicated significantly lower (p < 0.002, two-tailed t
test, df = 23) L1 copy number in AGS-1 hippocampus versus
controls (Figure 4D). Finally, the results of the L1 CNV assay
were strongly correlated (R2 = 0.93) with the mean somatic L1
insertion frequencies estimated by single-cell RC-seq (Figure 4E). We therefore concluded that L1 mobilization was unlikely to be elevated in AGS-1 hippocampus.

234 Cell 161, 228–239, April 9, 2015 ª2015 The Authors

(A) A 6 kb L1-Ta element incorporates 50 and 30 UTRs and two ORFs. ORF2p
presents EN and RT domains. Methylation of a CpG island present in the 50
UTR regulates L1 promoter activity. The locations of two capture probes used
by RC-seq are indicated below the L1. Note: TSDs and probes are not drawn
to scale. See also Figure S2.
(B) TPRT hallmark features, including TSDs and an L1 EN recognition motif,
can be identified by RC-seq, including for insertions detected at only a 50 or 30
L1-genome junction.
(C) Consensus L1 EN motifs for polymorphic and somatic L1 insertions detected at their 50 and 30 L1-genome junctions, and somatic L1 insertions found
at only a 30 L1-genome junction.
(D) Observed TSD size distributions for polymorphic and somatic L1 insertions,
normalized to random expectation. See also Figure S6.

Somatic L1 Retrotransposition Occurs via TPRT
As the 13 total somatic L1 insertions detected by single-cell RCseq and validated by PCR generally followed the TPRT model,
we next assessed whether somatic L1 insertions detected by
bulk RC-seq also carried TPRT signatures. RC-seq separately
applied to DNA extracted from the four control hippocampus
samples elucidated 318,866 putative somatic L1 insertions
(Table S1). Again exploiting L1-genome junction resolution by
RC-seq reads (Figures 6A and 6B and S2), we found a strong
enrichment for the L1 EN motif (Figure 6C), a typical TSD size
range of 5–35 nt (Figures 6D and S6) and a median L1 poly-A
tail length of 33 nt for somatic L1 integration sites identified by
bulk RC-seq. We also identified a substantial group of insertions

with TSDs > 40 bp in length (Figure S6). Thus, single-cell RC-seq
and RC-seq applied to bulk DNA both elucidated the hallmark
sequence features of TPRT-mediated retrotransposition.
Somatic L1 Insertions Are Enriched in Neurobiology
Genes
Substrate DNA chromatinization modulates L1 EN target site
nicking in vitro (Cost et al., 2001). As such, dynamic changes
to chromatin state during neurogenesis may impact the associated genome-wide pattern of L1 mobilization. An intersection
of somatic L1 insertion sites detected by hippocampus bulk
RC-seq with RefSeq gene coordinates revealed significant (p <
1.0 3 10150, Fisher’s exact test, Bonferroni correction) depletion for insertions in exons and promoters versus random sampling and significant (p < 3.8 3 1010) enrichment for introns
versus polymorphic insertions (Table S3). Exons and introns carrying gene ontology (GO) terms relevant to neurobiology were
however enriched for somatic L1 insertions (Tables S4 and S5)
compared with random sampling performed by gene identifier
or by genomic coordinate (p < 4.5 3 105 and p < 0.03, respectively, Fisher’s exact test, Benjamini-Hochberg correction). The
latter result indicated enrichment for L1 insertions in genes expressed in the brain, despite taking into account that their length
is on average >50% greater than that of other genes. By considerable margin, the most enriched GO term found (Table S5) was
‘‘regulation of synapse maturation’’ (p < 1.7 3 1060, Fisher’s
exact test, Benjamini-Hochberg correction). Genome-wide patterns for somatic L1 insertions detected in glia and neurons by
single-cell RC-seq typically corroborated those found by bulk
RC-seq, including enrichment in introns and depletion from promoters and exons (Table S3) and even stronger enrichment in
neurobiology genes annotated by GO term (Tables S4 and S5).
Intriguingly, in AGS-1 hippocampal neurons we did not observe
enrichment for L1 insertions in neurobiology genes (Table S4),
whereas enrichment was observed for control hippocampal neurons, even if each individual was analyzed separately. As a control experiment, from the liver bulk RC-seq data we identified a
set of 175 potential liver-specific L1 insertions (see Extended
Experimental Procedures) that collectively presented a clear L1
EN consensus motif (Figure S6D) and, owing to the sensitivity
of bulk RC-seq, were unlikely to represent incorrectly annotated
polymorphic L1 insertions (Table S1). Notably, these liver-specific L1 insertions exhibited no enrichment for neurobiology
genes (Table S4). We concluded that somatic L1 retrotransposition in neural cells preferentially occurs into the euchromatic regions of the genome contributing to neurobiology.
Hippocampal L1 Insertions Prefer Genomic Loci
Transcribed in the Hippocampus
Open chromatin is a typical prerequisite for efficient transcription
(Neph et al., 2012). With this in mind, we used single-molecule
cap analysis of gene expression (CAGE) transcriptome profiling
data from the FANTOM5 consortium (Forrest et al., 2014) to
test whether genes strongly transcribed in the hippocampus
were specifically enriched for somatic L1 insertions in hippocampal neurons. We first identified genes differentially upregulated in
hippocampus, cortex, caudate nucleus, liver, or heart tissue surveyed by CAGE and then intersected these gene lists with the

cohort of intragenic somatic L1 insertions detected by singlecell RC-seq applied to hippocampal neurons. Only those genes
upregulated in hippocampus versus heart, and hippocampus
versus liver, were significantly enriched (p < 0.05, Fisher’s exact
test, Benjamini-Hochberg correction) for insertions (Figure 7A,
Table S6). Somatic L1 insertions in hippocampal glia were
also most enriched in genes upregulated in the hippocampus
(p < 0.07). No enrichment was observed for cortical neurons
while, intriguingly, the liver-specific L1 insertion cohort exhibited
enrichment (p < 0.11) in genes upregulated in liver versus hippocampus (Figure 7A). Finally, we calculated the significance of
enrichment for hippocampal neuron L1 insertions in genes
upregulated in hippocampus while incrementally introducing putative artifacts described in Figure 5B. We found that statistical
significance was no longer achieved once the dataset contained
15% or more artifacts (Figure 7B), hence demonstrating how
experimental noise reduced in single-cell RC-seq analyses
would otherwise obscure genome-wide enrichment. These experiments altogether reveal context-dependent, preferential L1
mobilization into strongly transcribed loci.
Noting that euchromatin is also a signature of active
enhancer elements, we intersected our list of somatic L1 insertions detected by hippocampus bulk RC-seq with an extensive
FANTOM5 catalog of transcribed constitutive and cell-type specific enhancers defined by histone modifications and CAGEdelineated transcriptional activity (Andersson et al., 2014).
Globally, no substantial difference was observed in the rate of
L1 insertions in all enhancers versus random expectation. However, of 47 cell-type specific enhancer sets, only neuronal stem
cell enhancers were significantly enriched for somatic L1 insertions, compared with random expectation (p < 0.01, Fisher’s
exact test, Bonferroni correction) and compared with the union
of the remaining 46 cell-type specific enhancer sets (Figure 7C;
p < 1.0 3 104, Fisher’s exact test). This enrichment was highest
for L1 insertions within 100 nt of an enhancer, and was observed
up to 500 nt from defined enhancer boundaries (Figure 7D).
No enrichment was observed for astrocytes or for other cells
not of the neuronal lineage, such as hepatocytes (Figure 7D).
The smaller cohorts of somatic L1 insertions detected by single-cell RC-seq and liver bulk RC-seq were insufficient to
perform meaningful statistical analyses of L1 insertional preference with regards to enhancers. Nonetheless, hippocampus
bulk RC-seq indicated that neuronal stem cell-specific enhancers were the most highly enriched genome functional
element in absolute terms (1.8-fold) for somatic L1 insertions.
This reinforced the view that L1 mobilization during neurogenesis
impacts regulatory and protein-coding loci specifically active in
the hippocampus.
A Potential Signature of Neurogenic L1 Selection
De novo germline L1 insertions can be highly deleterious to gene
function, and commonly undergo purifying selection (Boissinot
et al., 2001; Han et al., 2004). The L1 ORF2 segment of sense oriented intronic L1 insertions particularly hinders RNA polymerase
processivity (Han et al., 2004; Lee et al., 2012). Hence, while
sense and antisense intronic L1 insertions are assumed to occur
with equal frequency in the germline, sense insertions are
selected against more strongly and tend to be eliminated from
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Figure 7. Genome-Wide Somatic L1 Insertion Patterns
(A) Somatic L1 insertions detected by single-cell RC-seq in hippocampal neurons and glia were enriched in genes differentially upregulated in hippocampus.
Liver-specific L1 insertions detected by bulk RC-seq were moderately enriched in genes upregulated in liver. No enrichment was observed for cortical neurons.
Color intensity is based on the absolute log2 transformed p value determined by Fisher’s exact test (Benjamini-Hochberg correction) with blue and orange colors
representing depletion and enrichment, respectively. Note: in each matrix pairwise comparison, the more highly expressed tissue is on the y axis.
(B) Hippocampal somatic L1 insertions were statistically enriched in genes upregulated in hippocampus versus liver (black) or hippocampus versus heart (gray),
as shown in (A). However, as previously filtered molecular chimeras (see Figure 5B) were re-introduced into this dataset, enrichment rapidly became no longer
significant.
(C) Of the transcribed cell-type specific enhancers defined by FANTOM5, only those of neuronal stem cells were enriched (observed/expected) for somatic L1
insertions detected by bulk hippocampus RC-seq, compared with other enhancers (p < 1.0 3 104, Fisher’s exact test, Bonferroni correction).
(D) Somatic L1 insertion enrichment in neuronal stem cell enhancers (black) extended 500 bp from enhancer boundaries. No enrichment was observed for
astrocyte (gray) or hepatocyte (red) enhancers.
See also Tables S2, S3, S4, S5, and S6.

the population. It follows that an estimated 43.3% of recent intronic L1-Ta insertions are sense oriented, versus only 34.1%
of fixed L1-Ta insertions and 39.7% of all polymorphic L1-Ta insertions (Ewing and Kazazian, 2010). By contrast, sense oriented
intronic L1 insertions are not depleted in tumors (Lee et al., 2012).
Among the control individuals examined here, we found that, as
expected, 42/101 (41.6%) of intronic, polymorphic germline L1
insertions were sense oriented to their host gene. Surprisingly,
406/1,024 (39.6%) of intronic somatic L1 insertions detected in
hippocampal neurons by single-cell RC-seq were also sense oriented, significantly less than the expected 50% (p < 0.0001,
exact binomial test). This proportion was 47/136 (34.6%) and
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166/503 (33.0%) for glia and cortical neurons, respectively.
Adhering to the prevailing germline model of L1 evolutionary selection, we concluded that some somatic L1 insertions may arise
sufficiently early in neurogenesis to impact neural progenitor cell
fitness, as indicated by a depletion of sense oriented events in
mature neurons and glia.
DISCUSSION
Our experiments firmly establish that L1-driven mosaicism pervades the hippocampus and is mediated by TPRT. That we
found 13.7 somatic L1 insertions per hippocampal neuron was

unexpected given a prior estimate of <0.1 insertions per cortical
neuron (Evrony et al., 2012). By discovering here a myriad of L1
insertions in cortical neurons, we exclude a biological explanation for this discrepancy and instead propose that the process
by which the earlier work selected insertions for validation led
to a significant underestimate of L1 retrotransposition frequency.
Indeed, the mobilization rate reported here much more closely
resembles an earlier estimate of 80 somatic L1 insertions per
brain cell, calculated via L1 qPCR (Coufal et al., 2009).
Beyond this, our data demonstrate that L1 insertions in hippocampal neurons and glia are preferentially found in protein-coding genes highly transcribed in the hippocampus. Transcribed
enhancers active in neuronal stem cells are also enriched for somatic L1 insertions, indicating likely L1 perturbation of regulatory
elements. L1 insertions in cortical neurons were however not
significantly enriched in genes highly transcribed in the cortex.
We speculate that this could be due to cortical neurogenesis primarily occurring during fetal development (Spalding et al., 2005),
which presents a genome-wide transcriptional profile different to
that of the adult cortex. Although L1 mobilization was not
increased in AGS-1 hippocampal neurons, the pattern of L1 insertions was prospectively different to that of controls, the reasons for which are presently unclear. The most obvious caveat
of this analysis is that, due to the extreme rarity of the disease,
only one AGS patient hippocampus was studied. Nonetheless,
this experiment serves as a proof-of-principle demonstration
that single-cell RC-seq could be used in the future to assess
abnormal L1 mobilization in neurological disease. Finally, we
noted that somatic L1 insertions in neurons bore substantially
longer TSDs on average than polymorphic L1 insertions, corroborated by structural characterization of L1 integration sites found
by single-cell RC-seq. Unusually long TSDs have previously
been identified using an engineered L1 reporter system in
HeLa cells (Gilbert et al., 2005). As also hypothesized in that
context, pervasive euchromatinization in neural progenitor cells
may promote the formation of long TSDs.
The predominant developmental timing of endogenous L1
mobilization in the brain remains unclear. Although the vast majority of somatic L1 insertions detected by single-cell RC-seq
were found in one cell each, a small proportion of L1s were detected in multiple cells, including examples found in both glia
and neurons, indicating L1 mobilization in a common multipotent
progenitor cell. Three somatic L1 insertions were validated by
PCR in multiple neurons, including one example found in nearly
50% of the neurons assayed. Thus, although most L1 insertions
may occur in one or a handful of neurons, a substantial number
appear to arise during early neurogenesis. Indeed, the signature
of potential selection against somatic L1 insertions sense oriented to host gene introns suggests that many retrotransposition
events precede terminal neural cell maturation. We speculate
that depletion of these events could be explained by preferential
L1 integration into neurogenesis genes, thereby impacting the
survival or differentiation potential of neural progenitor cells. It
also cannot be excluded that somatic L1 integration primarily occurs antisense to host gene introns, though we currently lack a
mechanistic explanation for this preference.
Neuronal genome mosaicism may not be restricted to somatic
L1 insertions. Alu and SVA retrotransposons trans mobilized by

L1 may also contribute mosaic insertions. Other than transposable element activity, recent studies have reported localized
and chromosome-wide CNV in normal neurons (Cai et al.,
2014; Gole et al., 2013; McConnell et al., 2013). We find no definitive evidence of these events in our data, though it must be
noted that our CNV analyses were expressly geared to discern
genomic deletions caused by WGA failure or variability. However, it must be noted that we found consistent WGA inefficiency
at telomeres, while others have reported that most apparent
small genomic deletions occur close to telomeres (McConnell
et al., 2013).
L1 mosaicism may also occur outside of the brain, for
instance during early embryogenesis (Garcia-Perez et al.,
2007; Kano et al., 2009) or, as we previously reported for a single
L1 insertion, in the liver (Shukla et al., 2013). However, some cell
types present practical and technical challenges not posed
by neural cells. For example, hepatocytes are frequently multinucleated and sustain aneuploidy and polyploidy, greatly
complicating single-cell genomic analysis. Thus, although the
liver-specific L1 insertions detected here by bulk RC-seq
consistently bore L1 EN motifs and were enriched in genes
differentially upregulated in liver, we were unable to corroborate
these findings with single-cell RC-seq or downstream PCR validation. Future methodological advances will therefore likely be
required to elucidate L1 mosaicism in the liver, and elsewhere
in the body.
The capacity to locate somatic L1 insertions in individual
neural cell genomes is a major step toward determining whether
mosaicism impacts neurobiological function. Limitations in assaying the transcriptome and genome of the same cell however
currently prohibit functional assays of individual somatic L1 insertions. Nonetheless, given the frequency of these events, their
mutagenic potential for protein-coding and regulatory regions
and an apparent preference for euchromatic DNA linked to
neurobiological function, it is not unreasonable to predict that
L1-driven somatic mosaicism may alter the functional properties
of the brain.
EXPERIMENTAL PROCEDURES
Full protocols can be found in the Extended Experimental Procedures.
Samples
Control tissues were provided by the Edinburgh Sudden Death Brain and
Tissue Bank. Tissues were obtained post-mortem from AGS-1 with ethical
approval to be used as described. AGS-1 carried SAMHD1 mutations c.646647 delAT (p.Met216fs) and c.1223G>C (p.Arg408Pro). Patient age and
gender information is provided in Table S1.
Single-Cell RC-Seq
NeuN+ (neuronal) and NeuN–/Ki67– (glial) nuclei were isolated via FACS
from brain tissue, individually picked under microscope and subjected to
linear WGA. Products were split into three exponential PCR reactions
utilizing two different kits, and then combined for library preparation and
downstream PCR validation. Multiplexed Illumina libraries were pooled and
sequenced (2 3 150-mer reads) to assess allelic dropout and L1-genome
junction depletion, then hybridized separately to two LNA probes respectively
matching the 5ʹ and 3ʹ ends of L1-Ta. Post-enrichment, RC-seq libraries were
sequenced (2 3 150-mer reads), computationally processed, filtered to
exclude artifacts, and finally used to call polymorphic and somatic L1
insertions.
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50 L1-Genome Junction Validation and Characterization
Twenty somatic L1 insertions detected by single-cell RC-seq at a 30 L1genome junction were selected at random for structural characterization by
PCR amplification and sequencing of the corresponding 50 L1-genome junction. For each example, initial PCR template DNA consisted of WGA material
from the relevant neuron. As the extent of L1 50 truncation was unknown,
primers oriented antisense to L1 were designed approximately every 500 bp
through the L1-Ta consensus and combined with an insertion site primer
unique to each locus. 50 L1-genome junctions were identified by PCR and
sequencing and then separately PCR amplified again using WGA material
from the selected neuron, WGA material from other single neurons from the
same individual, as well as matched bulk DNA. Amplified material was stored
and handled separately to bulk DNA.
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Li, W., Prazak, L., Chatterjee, N., Grüninger, S., Krug, L., Theodorou, D., and
Dubnau, J. (2013). Activation of transposable elements during aging and
neuronal decline in Drosophila. Nat. Neurosci. 16, 529–531.
Luan, D.D., Korman, M.H., Jakubczak, J.L., and Eickbush, T.H. (1993).
Reverse transcription of R2Bm RNA is primed by a nick at the chromosomal
target site: a mechanism for non-LTR retrotransposition. Cell 72, 595–605.
Macfarlane, C.M., Collier, P., Rahbari, R., Beck, C.R., Wagstaff, J.F., Igoe, S.,
Moran, J.V., and Badge, R.M. (2013). Transduction-specific ATLAS reveals a
cohort of highly active L1 retrotransposons in human populations. Hum. Mutat.
34, 974–985.

Neph, S., Vierstra, J., Stergachis, A.B., Reynolds, A.P., Haugen, E., Vernot, B.,
Thurman, R.E., John, S., Sandstrom, R., Johnson, A.K., et al. (2012). An expansive human regulatory lexicon encoded in transcription factor footprints. Nature 489, 83–90.
Perrat, P.N., DasGupta, S., Wang, J., Theurkauf, W., Weng, Z., Rosbash, M.,
and Waddell, S. (2013). Transposition-driven genomic heterogeneity in the
Drosophila brain. Science 340, 91–95.
Raiz, J., Damert, A., Chira, S., Held, U., Klawitter, S., Hamdorf, M., Löwer, J.,
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